Cooper Companies (COO) stock

Health Care · Health Care Supplies

$61.21
-$0.44 -0.71%
Close

Cooper Companies (COO) is a Health Care Supplies company in the Health Care sector, headquartered in San Ramon, California. As of October 23, 2026, COO closed at $61.21, a market capitalization of $11.64 billion, the 478th largest company in the S&P 500. Over the last twelve months it generated $4.24 billion in revenue (+1% year over year) and $678.00 million in free cash flow. The stock trades at 21.0x trailing earnings and 13.0x forward earnings.

  • 1-year total return: -17.9% (dividends reinvested)
  • 5-year return: -10.1% a year
  • 52-week range: $51.01 – $89.83
  • Gross margin 65.9%, operating margin 20.8%
  • FI Handbook report card: B- across 10 metrics
  • 55th largest of 60 Health Care stocks in the S&P 500

COO price chart

1Y price change: -17.9% (price only; total returns below include dividends)

$60.00
$70.00
$80.00
Nov2026MarMayJulSep
COO total returns
Total return1MYTD1Y3Y5Y10YMAX
COO+9.2%-25.3%-17.9%-8.8%-10.1%+3.2%+5.0%

Dividends reinvested. 3Y and longer are annualized; MAX is annualized since 1983.

COO key statistics

Market cap
$11.6B
#478 in S&P 500
P/E (TTM)
21.0x
Forward P/E
13.0x
EPS (TTM)
$2.91
Revenue (TTM)
$4.2B
+1%
Free cash flow
$678.0M
Gross margin
65.9%
Operating margin
20.8%
Return on equity
6.8%
Dividend yield
None
52-week range
$51.01 – $89.83
Beta
0.82
Price / sales
2.7x
EV / EBITDA
15.3x
Debt / equity
0.34x
Employees
15,000

COO report card

B-

Ten fundamentals graded A to F against fixed thresholds. Not a buy or sell rating.

  • Revenue growth0.6%D
  • Gross margin65.9%A
  • Operating margin20.8%B
  • FCF margin16.0%B
  • Return on equity6.8%D
  • Net debt / EBITDA2.8xD
  • Forward P/E13.0xA
  • PEG ratio0.5xA
  • Shareholder yield2.5%C
  • Share count change / yr0.2%C

Cooper Companies financials

Revenue went from $2.0B in fiscal 2016 to $4.1B in fiscal 2025, growing 8.5% a year.

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Cooper Companies annual financial results
Fiscal year2016201720182019202020212022202320242025
Revenue$2.0B$2.1B$2.5B$2.7B$2.4B$2.9B$3.3B$3.6B$3.9B$4.1B
Gross profit$1.2B$1.4B$1.6B$1.8B$1.5B$2.0B$2.1B$2.4B$2.6B$2.7B
Operating income$324.1M$429.1M$403.1M$546.7M$311.8M$505.8M$507.6M$533.1M$705.7M$682.9M
Net income$273.9M$372.9M$139.9M$466.7M$238.4M$2.9B$385.8M$294.2M$392.3M$374.9M
EPS (diluted)$1.40$1.88$0.70$2.33$1.20$14.79$1.94$1.48$1.96$1.87
Free cash flow$357.0M$466.4M$475.3M$421.1M$176.2M$524.2M$450.4M$215.0M$288.1M$433.7M
Buybacks$0$55.0M$0$156.1M$47.8M$24.8M$78.5M$0$0$290.1M
Dividends paid$2.9M$2.9M$2.9M$3.0M$3.0M$3.0M$3.0M$3.0M$0$0
Diluted shares196.0M198.4M198.8M200.0M198.4M199.2M198.8M199.3M200.4M200.0M

Source: SEC filings (10-K XBRL). EPS and share counts are split-adjusted.

PRO
15 years of financials, quarterly data and CSV export

Coming with FI Handbook Pro.

See Pro

What's priced into COO?

A reverse DCF asks what growth the current price requires. With an enterprise value of $14.3B and $678.0M of trailing free cash flow, Cooper Companies needs to grow free cash flow about 11.9% a year for ten years (fading to 3.0% terminal growth) to earn a 10% annual return. For context, free cash flow grew 19.7% a year over the last five years.

P/E ratio history

Current 32.7x vs. median 32.6x (10th–90th percentile 17.8x–77.2x).

0x
50x
100x
20122014201620182020202220242026

A model, not a forecast or advice. Small changes in assumptions move the answer a lot.

COO earnings

Next report: December 10, 2026. Cooper Companies has beaten EPS estimates 8 quarters in a row. Last quarter's revenue was $1.1B (+1% year over year).

Report dateEPS estimateEPS actualSurprise
Sep 9, 2026$1.12$1.15+2.7%
Jun 4, 2026$1.09$1.21+10.5%
Mar 5, 2026$1.03$1.10+7.0%
Dec 4, 2025$1.11$1.15+3.3%
Aug 27, 2025$1.07$1.10+3.0%
May 29, 2025$0.93$0.96+3.3%
Mar 6, 2025$0.91$0.92+0.9%
Dec 5, 2024$1.00$1.04+4.0%

Stocks like COO

NameToday1YMkt capP/E
WST West Pharmaceutical Services, I-0.48%+28%$27.6B50.2xCompare
ALGN Align Technology-0.64%+14%$11.0B26.9xCompare
LLY Eli Lilly and-2.54%+56%$1.1T42.7xCompare
JNJ Johnson & Johnson-1.42%+40%$635.1B40.0xCompare
ABBV AbbVie+0.16%+29%$504.8B80.7xCompare
UNH UnitedHealth-1.62%+19%$375.3B26.9xCompare
MRK Merck &-1.34%+72%$358.4B117.2xCompare
TMO Thermo Fisher Scientific-0.40%+18%$249.1B35.5xCompare
Make a shareable COO chartFree infographics for X, Reddit and your blog.

COO news

COO stock FAQ

What is COO's market cap?

Cooper Companies's market capitalization is $11.64 billion as of October 23, 2026, ranking 478th in the S&P 500.

What is COO's P/E ratio?

COO trades at a trailing price-to-earnings ratio of 21.0x and a forward P/E of 13.0x. Its median P/E over the period we track is 32.6x.

Does COO pay a dividend?

No. Cooper Companies does not currently pay a regular cash dividend.

How much has COO stock returned?

Including reinvested dividends, COO returned -17.9% over one year, -10.1% a year over five years, +3.2% a year over ten years through October 23, 2026.

Is COO stock overvalued?

At today's price, a reverse discounted cash flow model (10% discount rate, 3% terminal growth) implies Cooper Companies must grow free cash flow about 12% a year for the next decade. Its free cash flow grew 20% a year over the last five years. Whether that is achievable decides if the stock is cheap or expensive. This is a model, not advice.

When does COO report earnings?

Cooper Companies is expected to report earnings on December 10, 2026. It has beaten EPS estimates 8 quarters in a row.

How many employees does Cooper Companies have?

Cooper Companies has about 15,000 full-time employees, or $282,460 of revenue per employee.

Sources: SEC EDGAR filings, Yahoo Finance market data (delayed), FI Handbook calculations. Last close October 23, 2026. Methodology